Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06097468
What this trial is testing

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
University of California, San Francisco 40
Not applicableWithdrawnNCT02295540
What this trial is testing

Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Stage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Verrucous Carcinoma of the Oral CavityStage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity+4 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Study completedNCT00021320
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fox Chase Cancer Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT02503423
What this trial is testing

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

Who this might be right for
Solid TumorsLymphoma
Taiho Oncology, Inc. 253
Testing effectiveness (Phase 2)Study completedNCT00003850
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 47
Not applicableStudy completedNCT01663259
What this trial is testing

Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV
University of Michigan Rogel Cancer Center 43
Large-scale testing (Phase 3)Study completedNCT02551159
What this trial is testing

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 823
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Early research (Phase 1)Active Not RecruitingNCT06806852
What this trial is testing

Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Boehringer Ingelheim 91
Testing effectiveness (Phase 2)Study completedNCT03313804
What this trial is testing

Priming Immunotherapy in Advanced Disease With Radiation

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
John L. Villano, MD, PhD 76
Early research (Phase 1)Ended earlyNCT02819752
What this trial is testing

PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma
Royal Marsden NHS Foundation Trust 3
Large-scale testing (Phase 3)WithdrawnNCT01142414
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)UnknownNCT04597476
What this trial is testing

A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck

Who this might be right for
Squamous Cell Carcinomas of the Head and Neck
Hi-Q Marine Biotech International, Ltd. 119
Early research (Phase 1)Study completedNCT03245489
What this trial is testing

Anti-platelet + Pembro for H&N Tumors

Who this might be right for
Head and Neck Cancer
Medical University of South Carolina 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05044897
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 11
Large-scale testing (Phase 3)Study completedNCT01137123
What this trial is testing

Improve the Treatment of Thoracic Esophageal Cancer

Who this might be right for
Thoracic Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 301
Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT01243398
What this trial is testing

Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
University of Oxford 450
Large-scale testing (Phase 3)Active Not RecruitingNCT03769506
What this trial is testing

ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy

Who this might be right for
Head and Neck Cancer
Rakuten Medical, Inc. 135
Next Page